Evidence map›Paper›PMID 38757723›Full record

ArticleRenal failure2024

β-Hydroxybutyrate Protects Against Cisplatin-Induced Renal Damage via Regulating Ferroptosis.

Ruixue Tian, Shuqin Tang, Jingyu Zhao, Yajie Hao, Limei Zhao, Xiutao Han, Xingru Wang, Lijun Zhang, Rongshan Li, Xiaoshuang Zhou

Abstract read
In one paragraph

Article in Renal failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruixue TianDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.ORCID 0000-0003-1193-9913
Shuqin TangDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Jingyu ZhaoThe Third Clinical Medical College, Shanxi University of Chinese Medicine, Jinzhong, China.
Yajie HaoDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Limei ZhaoDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Xiutao HanThe Third Clinical Medical College, Shanxi University of Chinese Medicine, Jinzhong, China.
Xingru WangDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Lijun ZhangDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.
Rongshan LiDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University; Shanxi Kidney Disease Institute, Taiyuan, China.
Xiaoshuang ZhouDepartment of Nephrology, Shanxi Provincial People's Hospital; The Fifth Clinical Medical College of Shanxi Medical University; Shanxi Kidney Disease Institute, Taiyuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cisplatin is a particularly potent antineoplastic drug. However, its usefulness is restricted due to the induction of nephrotoxicity. More recent research has indicated that β-hydroxybutyrate (β-HB) protects against acute or chronic organ damage as an efficient healing agent. Nonetheless, the therapeutic mechanisms of β-HB in acute kidney damage caused by chemotherapeutic drugs remain unclear. Our study developed a model of cisplatin-induced acute kidney injury (AKI), which involved the administration of a ketogenic diet or β-HB. We analyzed blood urea nitrogen (BUN) and creatinine (Cr) levels in serum, and used western blotting and immunohistochemical staining to assess ferroptosis and the calcium/calmodulin-dependent kinase kinase 2 (Camkk2)/AMPK pathway. The mitochondrial morphology and function were examined. Additionally, we conducted

Indexed as

3-Hydroxybutyric AcidAcute Kidney InjuryCalcium-Calmodulin-Dependent Protein Kinase KinaseCisplatinFerroptosisAMP-Activated Protein KinasesAnimalsAntineoplastic AgentsBlood Urea NitrogenCreatinineDisease Models, AnimalHumansKidneyMaleMiceMice, Inbred C57BL3-Hydroxybutyric AcidAMP-Activated Protein KinasesAntineoplastic AgentsCalcium-Calmodulin-Dependent Protein Kinase KinaseCisplatinCreatinineAMPKCamkk2cisplatinferroptosisnephrotoxicityβ-hydroxybutyrate

Identifiers

PMID38757723
PMCPMC11104694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.